Literature DB >> 6793337

Behaviour of IOP and pupil size after topical tranylcypromine in the rabbit eye.

P F Hoyng, G W van Alphen.   

Abstract

Repeated topical administration of tranylcypromine (TCP) to adult rabbit eyes causes a transient rise in intraocular pressure (IOP) for one half hour and a dilatation of the pupil for more than two hours. These effects are blocked by phenoxybenzamin but not by timolol. Indomethacin blocks the rise in pressure but not the pupillary dilatation. Chemical denervation blocks both effects. The rise in IOP is not followed by a hypotensive phase. It is suggested that TCP has a dual effect on the eye. Firstly, TCP as a releaser of endogenous nor-epinephrine (nE) and as a monoamine oxydase inhibitor will induce accumulation of nE at the receptor-side which in turn probably stimulates the synthesis of PGs to raise IOP. Secondly, TCP as a prostacyclin synthase inhibitor may be responsible for the absence of a hypotensive response. This is strengthened by the finding that TCP inhibits the hypotensive response to nE but potentiates the dilatation of the pupil.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6793337     DOI: 10.1007/BF00143886

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  18 in total

1.  Species differences in the cardiac effects of a monoamine oxidase inhibitor.

Authors:  N D GOLDBERG; F E SHIDEMAN
Journal:  J Pharmacol Exp Ther       Date:  1962-05       Impact factor: 4.030

2.  Pargyline drops in glaucoma.

Authors:  K S Mehra; P N Roy; R Singh
Journal:  Arch Ophthalmol       Date:  1974-12

3.  Increased intraocular pressure produced by prostaglandins E1 and E2 in the cat eye.

Authors:  K E Eakins
Journal:  Exp Eye Res       Date:  1970-07       Impact factor: 3.467

4.  Differential effects of inhibitors of monoamine oxidase Types A and B on the adrenergic system of the rabbit iris.

Authors:  E A Zeller; P A Knepper; D Shoch
Journal:  Invest Ophthalmol       Date:  1975-02

5.  Potentiation of the mydriatic effect of norepinephrine in the rabbit after monoamine oxidase inhibition.

Authors:  B K Colasanti; E H Bárány
Journal:  Invest Ophthalmol Vis Sci       Date:  1979-02       Impact factor: 4.799

6.  Enzymology of the refractory media of the eye. IX. On the role of monoamine oxidase in the regulation of aqueous humor dynamics of the rabbit eye.

Authors:  E A Zeller; D Shoch; S G Cooperman; R I Schnipper
Journal:  Invest Ophthalmol       Date:  1967-12

7.  Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation.

Authors:  S Bunting; R Gryglewski; S Moncada; J R Vane
Journal:  Prostaglandins       Date:  1976-12

8.  Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.

Authors:  R J Gryglewski; S Bunting; S Moncada; R J Flower; J R Vane
Journal:  Prostaglandins       Date:  1976-11

9.  The high yield of prostacyclin biosynthesis by the iris and its effects on the intraocular muscles.

Authors:  G W van Alphen; C E Dutilh; E A de Deckere
Journal:  Prostaglandins Med       Date:  1978-08

10.  Effects of prostaglandins and a prostaglandin antagonist on intraocular pressure and protein in the monkey eye.

Authors:  R G Kelly; M S Starr
Journal:  Can J Ophthalmol       Date:  1971-07       Impact factor: 1.882

View more
  3 in total

1.  Does prostacyclin mediate alpha-adrenergic induced hypotension?

Authors:  P F Hoyng; G W van Alphen; E Haddeman
Journal:  Doc Ophthalmol       Date:  1982-09-30       Impact factor: 2.379

2.  Prevention of the excitatory actions of bradykinin by inhibition of PGI2 formation in nodose neurones of the guinea-pig.

Authors:  D Weinreich; G M Koschorke; B J Undem; G E Taylor
Journal:  J Physiol       Date:  1995-03-15       Impact factor: 5.182

3.  Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man.

Authors:  P Bitsios; R W Langley; S Tavernor; K Pyykkö; M Scheinin; E Szabadi; C M Bradshaw
Journal:  Br J Clin Pharmacol       Date:  1998-06       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.